功能性肠病中肠道微生物群的治疗性调节
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.
作者信息
Lee Hyo Jeong, Choi Jong Kyoung, Ryu Han Seung, Choi Chang Hwan, Kang Eun Hee, Park Kyung Sik, Min Yang Won, Hong Kyoung Sup
机构信息
Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Internal Medicine, National Medical Center, Seoul, Korea.
出版信息
J Neurogastroenterol Motil. 2017 Jan 30;23(1):9-19. doi: 10.5056/jnm16124.
Abstract
Functional bowel disorders (FBDs) are functional gastrointestinal disorders with symptoms attributable to the middle or lower gastrointestinal tract. These include irritable bowel syndrome, functional bloating, functional constipation, functional diarrhea, and unspecified FBD. Increasing evidence has emerged of late that intestinal microbiota is involved in the pathogenesis of FBDs. In this review, the therapeutic benefits and future perspectives of the currently available strategies for modifying the gut microbiota in FBDs are described, focusing primarily on irritable bowel syndrome and functional constipation.
摘要
功能性肠病（FBDs）是一类功能性胃肠疾病，其症状归因于中、下消化道。这些疾病包括肠易激综合征、功能性腹胀、功能性便秘、功能性腹泻以及未特定的功能性肠病。近来，越来越多的证据表明肠道微生物群参与了功能性肠病的发病机制。在本综述中，描述了目前用于改变功能性肠病肠道微生物群的策略的治疗益处和未来前景，主要聚焦于肠易激综合征和功能性便秘。
相似文献
1
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.功能性肠病中肠道微生物群的治疗性调节
J Neurogastroenterol Motil. 2017 Jan 30;23(1):9-19. doi: 10.5056/jnm16124.
2
Washed microbiota transplantation improves symptoms and intestinal barrier function in patients with functional bowel disorders: a propensity-score matching analysis.经洗涤的微生物群移植可改善功能性肠病患者的症状和肠道屏障功能：倾向评分匹配分析。
BMC Gastroenterol. 2024 Jan 23;24(1):45. doi: 10.1186/s12876-024-03131-z.
3
Probiotics in functional bowel disorders.功能性肠病中的益生菌
Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):89-97. doi: 10.1016/j.bpg.2016.01.003. Epub 2016 Jan 14.
4
Dysbiosis in Functional Bowel Disorders.功能性肠病中的肠道菌群失调。
Ann Nutr Metab. 2018;72(4):296-306. doi: 10.1159/000488773. Epub 2018 Apr 25.
5
The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders.肠易激综合征及其他功能性肠病中的肠道微生物群
Gastroenterol Clin North Am. 2017 Mar;46(1):91-101. doi: 10.1016/j.gtc.2016.09.014.
6
Five-year follow-up of 263 cases of functional bowel disorder.263 例功能性肠病的 5 年随访。
World J Gastroenterol. 2013 Mar 7;19(9):1466-71. doi: 10.3748/wjg.v19.i9.1466.
7
Gut Microbiota and Chronic Constipation: A Review and Update.肠道微生物群与慢性便秘：综述与更新
Front Med (Lausanne). 2019 Feb 12;6:19. doi: 10.3389/fmed.2019.00019. eCollection 2019.
8
The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.粪便微生物群移植对肠易激综合征、功能性腹泻和功能性便秘患者精神症状的影响：一项开放标签观察性研究。
J Affect Disord. 2018 Aug 1;235:506-512. doi: 10.1016/j.jad.2018.04.038. Epub 2018 Apr 12.
9
Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.美国、加拿大和英国成年人中罗马 IV 功能性肠病的流行情况。
Gastroenterology. 2020 Apr;158(5):1262-1273.e3. doi: 10.1053/j.gastro.2019.12.021. Epub 2020 Jan 7.
10
[Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].[肠易激综合征中肠道微生物群的治疗性调节。从益生菌到粪便微生物群疗法]
MMW Fortschr Med. 2017 Dec;159(Suppl 7):1-5. doi: 10.1007/s15006-017-0338-3. Epub 2017 Dec 4.
引用本文的文献
1
Probiotics interventions modulating gut microbiota composition in individuals with intestinal constipation: Protocol of a systemic review and meta-analysis of randomized controlled trials.益生菌干预对便秘个体肠道微生物群组成的调节作用：随机对照试验的系统评价和荟萃分析方案
PLoS One. 2025 Jan 24;20(1):e0311799. doi: 10.1371/journal.pone.0311799. eCollection 2025.
2
Functional Abdominal Bloating and Gut Microbiota: An Update.功能性腹胀与肠道微生物群：最新进展
Microorganisms. 2024 Aug 14;12(8):1669. doi: 10.3390/microorganisms12081669.
3
The Effect of on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet-fed Rats Depending on Age and Sex.依年龄和性别而定，[具体因素]对高脂饮食喂养大鼠肠道微生物变化及代谢功能谱的影响
J Neurogastroenterol Motil. 2024 Apr 30;30(2):236-250. doi: 10.5056/jnm23096.
4
Effect of Probiotic Therapy on Hemodynamic Response Associated with Systemic Inflammatory Reaction and Antibiotic-Induced Dysbiosis in Chronic Experiments in Rats.益生菌治疗对慢性实验大鼠全身炎症反应和抗生素诱导的肠道菌群失调相关血流动力学反应的影响。
Bull Exp Biol Med. 2022 Apr;172(6):676-680. doi: 10.1007/s10517-022-05455-w. Epub 2022 May 2.
5
Validity and safety of ID-JPL934 in lower gastrointestinal symptom improvement.ID-JPL934 在改善下消化道症状方面的有效性和安全性。
Sci Rep. 2021 Jun 22;11(1):13046. doi: 10.1038/s41598-021-92007-3.
6
Development of a freeze-dried symbiotic obtained from rice bran.从米糠中获得的冻干共生体的研制。
Biotechnol Rep (Amst). 2021 May 24;30:e00636. doi: 10.1016/j.btre.2021.e00636. eCollection 2021 Jun.
7
Effect of Combined Live Probiotics Alleviating the Gastrointestinal Symptoms of Functional Bowel Disorders.联合使用活益生菌缓解功能性肠病胃肠道症状的效果
Gastroenterol Res Pract. 2020 Sep 17;2020:4181748. doi: 10.1155/2020/4181748. eCollection 2020.
8
Potential common factors associated with predisposition to common cold in middle-aged and elderly Japanese: A community-based cross-sectional study.日本中老年人易患普通感冒的潜在共同因素：一项基于社区的横断面研究。
Medicine (Baltimore). 2018 May;97(20):e10729. doi: 10.1097/MD.0000000000010729.
9
Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus.系统评价：益生菌在治疗下消化道症状中的应用——基于最新证据的国际共识。
Aliment Pharmacol Ther. 2018 Apr;47(8):1054-1070. doi: 10.1111/apt.14539. Epub 2018 Feb 20.
10
Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something.肠道微生物群与唾液诊断：口腔正迫不及待地向我们传达某些信息。
Biores Open Access. 2017 Oct 1;6(1):123-132. doi: 10.1089/biores.2017.0020. eCollection 2017.
本文引用的文献
1
Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?小肠细菌过度生长的呼气试验：一种富集肠易激综合征患者中利福昔明应答者的方法？
Am J Gastroenterol. 2016 Mar;111(3):305-6. doi: 10.1038/ajg.2016.32. Epub 2016 Mar 1.
2
A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.一项概念验证研究表明，在伴有小肠细菌过度生长的肠易激综合征中，抗生素比在不伴有小肠细菌过度生长的肠易激综合征中更有效：一项随机、双盲、安慰剂对照试验。
Eur J Gastroenterol Hepatol. 2016 Mar;28(3):281-9. doi: 10.1097/MEG.0000000000000557.
3
Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.综述：利福昔明治疗腹泻型肠易激综合征的潜在作用机制。
Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:37-49. doi: 10.1111/apt.13437.
4
Review article: the antimicrobial effects of rifaximin on the gut microbiota.综述文章：利福昔明对肠道微生物群的抗菌作用。
Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:3-10. doi: 10.1111/apt.13434.
5
Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.预测肠易激综合征患者对抗生素的反应
Dig Dis Sci. 2016 Mar;61(3):846-51. doi: 10.1007/s10620-015-3872-9. Epub 2015 Sep 11.
6
The gut microbiota and host health: a new clinical frontier.肠道微生物群与宿主健康：一个新的临床前沿领域。
Gut. 2016 Feb;65(2):330-9. doi: 10.1136/gutjnl-2015-309990. Epub 2015 Sep 2.
7
Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.低 FODMAP 饮食可改善肠易激综合征症状，优于传统饮食建议：一项随机对照试验。
Gastroenterology. 2015 Nov;149(6):1399-1407.e2. doi: 10.1053/j.gastro.2015.07.054. Epub 2015 Aug 5.
8
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome.肠易激综合征患者中丁酸和甲烷产生微生物的减少
Sci Rep. 2015 Aug 4;5:12693. doi: 10.1038/srep12693.
9
Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.非乳糜泻麸质敏感症缩小了肠易激综合征的范围：一项双盲随机安慰剂对照试验
Nutrients. 2015 Jun 5;7(6):4542-54. doi: 10.3390/nu7064542.
10
Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet.溃疡性结肠炎的粪便微生物群移植：时机未到。
Gastroenterology. 2015 Jul;149(1):15-8. doi: 10.1053/j.gastro.2015.05.030. Epub 2015 May 27.
Zotero 插件